Discovery of a Potent and Short−Acting Oral Calcilytic with a Pulsatile Secretion of Parathyroid Hormone
- 29 December 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 2 (3) , 238-242
Abstract
Short-acting oral calcilytics, calcium-sensing receptor (CaSR) antagonists, have been considered as alternatives for parathyroid hormone (PTH), an injectable bone anabolic drug used in the treatment of osteoporosis. Previously, we identified aminopropandiol 1, which transiently stimulated endogenous PTH secretion in rats. However, the inhibition of cytochrome P450 (CYP) 2D6 and the low bioavailability of 1 remain to be solved. Attempts to change the physicochemical properties of the highly lipophilic amine 1 by introduction of a carboxylic acid group as well as further structural modifications led to the discovery of the highly potent biphenylcarboxylic acid 15, with a markedly reduced CYP2D6 inhibition and a significantly improved bioavailability. Compound 15 evoked a rapid and transient elevation of endogenous PTH levels in rats after oral administration in a dose-dependent manner at a dose as low as 1 mg/kg. The PTH secretion pattern correlated with the pharmacokinetic profile and agreed well with that of the exogenous PTH injection which exerts a bone anabolic effect.Keywords
This publication has 17 references indexed in Scilit:
- Synthesis and structure–activity relationship of tetrahydropyrazolopyrimidine derivatives—A novel structural class of potent calcium-sensing receptor antagonistsBioorganic & Medicinal Chemistry, 2010
- Penta-substituted benzimidazoles as potent antagonists of the calcium-sensing receptor (CaSR-antagonists)Bioorganic & Medicinal Chemistry Letters, 2010
- New aminopropandiol derivatives as orally available and short-acting calcium-sensing receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2010
- Metabolism-Guided Design of Short-Acting Calcium-Sensing Receptor AntagonistsACS Medicinal Chemistry Letters, 2010
- 1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: A Novel Series of Potent Calcium-Sensing Receptor AntagonistsJournal of Medicinal Chemistry, 2010
- Antagonists of the Calcium Receptor. 2. Amino Alcohol-Based Parathyroid Hormone SecretagoguesJournal of Medicinal Chemistry, 2009
- Short-acting 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as orally-active calcium-sensing receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2009
- Discovery and Structure−Activity Relationships of Trisubstituted Pyrimidines/Pyridines as Novel Calcium-Sensing Receptor AntagonistsJournal of Medicinal Chemistry, 2009
- Parathyroid Hormone as an Anabolic Skeletal TherapyDrugs, 2005
- Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic ratsJournal of Clinical Investigation, 2000